000 01408 a2200397 4500
005 20250515024554.0
264 0 _c20070405
008 200704s 0 0 eng d
022 _a0049-3848
024 7 _a10.1016/j.thromres.2006.03.005
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDropinski, Jerzy
245 0 0 _aAntithrombotic effects of aspirin based on PLA1/A2 glycoprotein IIIa polymorphism in patients with coronary artery disease.
_h[electronic resource]
260 _bThrombosis research
_c2007
300 _a301-3 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article; Randomized Controlled Trial
650 0 4 _aAlleles
650 0 4 _aAspirin
_xadministration & dosage
650 0 4 _aBleeding Time
650 0 4 _aCoronary Artery Disease
_xgenetics
650 0 4 _aCyclooxygenase Inhibitors
_xadministration & dosage
650 0 4 _aHomozygote
650 0 4 _aHumans
650 0 4 _aIntegrin beta3
_xgenetics
650 0 4 _aMale
650 0 4 _aPolymorphism, Genetic
650 0 4 _aRetrospective Studies
650 0 4 _aThrombin Time
700 1 _aMusial, Jacek
700 1 _aSanak, Marek
700 1 _aWegrzyn, Wojciech
700 1 _aNizankowski, Rafal
700 1 _aSzczeklik, Andrew
773 0 _tThrombosis research
_gvol. 119
_gno. 3
_gp. 301-3
856 4 0 _uhttps://doi.org/10.1016/j.thromres.2006.03.005
_zAvailable from publisher's website
999 _c16276311
_d16276311